These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6235163)

  • 1. Hepatitis B vaccination in Down's syndrome and other mentally retarded patients.
    Heijtink RA; De Jong P; Schalm SW; Masurel N
    Hepatology; 1984; 4(4):611-4. PubMed ID: 6235163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].
    García Bengoechea M; Cortés A; Cabriada J; Albizu I; Dorronsoro M; Arriola JA; Arenas JI
    Med Clin (Barc); 1990 Apr; 94(14):528-30. PubMed ID: 2141377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal hepatitis B vaccination for mentally retarded patients.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W
    J Infect; 1989 Sep; 19(2):119-25. PubMed ID: 2530288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term observation of the effect of intradermal hepatitis B vaccination on mentally retarded patients.
    Hayashi J; Noguchi A; Nakashima K; Morofuji M; Kashiwagi S
    Eur J Epidemiol; 1991 Nov; 7(6):649-53. PubMed ID: 1838338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome.
    Van Damme P; Vranckx R; Meheus A
    Vaccine; 1990 Mar; 8 Suppl():S53-5; discussion S60-2. PubMed ID: 2139285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus infection among mentally retarded patients in institutions, Okinawa, Japan.
    Hayashi J; Kashiwagi S; Noguchi A; Nakashima K; Ikematsu H; Kajiyama W; Nomura H
    Fukuoka Igaku Zasshi; 1989 Sep; 80(9):436-40. PubMed ID: 2807128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers.
    Lohiya G; Lohiya S; Ngo VT; Crinella R
    Hepatology; 1986; 6(2):163-6. PubMed ID: 2937706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of HBeAg and anti-HBe in an institution for the mentally retarded.
    Gust ID; Dimitrakakis M; Sharma DL
    Aust N Z J Med; 1978 Oct; 8(5):471-3. PubMed ID: 154317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B infection among residents of an institution for the mentally retarded.
    Chaudhary RK; Perry E; Cleary TE
    Am J Epidemiol; 1977 Feb; 105(2):123-6. PubMed ID: 138362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A and B in non-institutionalized mentally retarded patients.
    Renner F; Andrle M; Horak W; Rett A
    Hepatogastroenterology; 1985 Aug; 32(4):175-7. PubMed ID: 2932380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunogenicity of the vaccine against the HBV in the mentally retarded].
    Cobo Soriano J; Gil Miguel A; Rey Calero J; Herrazo Cabrera R; Martín Hernández D
    Aten Primaria; 1991; 8(7):536, 538-40, 542. PubMed ID: 1836394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose intradermal vaccination against hepatitis B in mentally retarded patients.
    Heijtink RA; Breukers AA; den Hartigh G; Schepman RW; Schmitz PI; Schalm SW; Masurel N
    Vaccine; 1988 Feb; 6(1):59-61. PubMed ID: 2965462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.
    Troisi CL; Heiberg DA; Hollinger FB
    JAMA; 1985 Dec; 254(22):3196-9. PubMed ID: 2933533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients.
    Torre D; Broggini M; Botta V; Sampietro C
    Vaccine; 1989 Apr; 7(2):102-3. PubMed ID: 2526418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection in an institution for the mentally retarded.
    van Ditzhuijsen TJ; de Witte-van der Schoot E; van Loon AM; Rijntjes PJ; Yap SH
    Am J Epidemiol; 1988 Sep; 128(3):629-38. PubMed ID: 2970793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against hepatitis B in preschool children with Down's syndrome.
    Vajro P; Lettera P; Fontanella A; Sbreglia C; Manzillo E; Sartorio R; Del Giudice E
    J Intellect Disabil Res; 1992 Feb; 36 ( Pt 1)():77-81. PubMed ID: 1533557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to hepatitis B vaccine in the mentally retarded.
    Wahl M; Hermodsson S; Iwarson S
    J Infect; 1983 Jul; 7 Suppl 1():47-51. PubMed ID: 6232324
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B carriers in a centre for the mentally retarded in Finland and immunogenicity of hepatitis B vaccine.
    Mölsä PK
    J Ment Defic Res; 1990 Aug; 34 ( Pt 4)():379-83. PubMed ID: 2144593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patients.
    Cooper BW; Klimek JJ; Upadhyaya A; Devine S
    Am J Infect Control; 1986 Oct; 14(5):204-8. PubMed ID: 3641542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling long-term persistence of hepatitis B antibodies after vaccination.
    Vellinga A; Van Damme P; Bruckers L; Weyler JJ; Molenberghs G; Meheus A
    J Med Virol; 1999 Feb; 57(2):100-3. PubMed ID: 9892391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.